osu 6162
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 20, 2017 (NCT04127669)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Serotonin 2a (5-HT2a) receptorPARTIAL AGONIST
HTR2A partial agonist
- Dopamine D2 receptorPARTIAL AGONIST
DRD2 partial agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSV5SBJBUJW6 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05641623 | Phase 2 | Apr 21, 2022 | NeuroSearch A/S, University of Gothenburg |
| NCT05296356 | Phase 2 | Oct 25, 2021 | NeuroSearch A/S, University of Gothenburg |
| NCT03209830 | Phase 2 | Sep 5, 2017 | University of Gothenburg, University of Oslo |
| NCT04127669 | Phase 2 | Mar 20, 2017 | Gottfries Clinic AB, NeuroSearch A/S |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NeuroSearch A/S | For profit | 3 | 1 | 1 | 2017 |
| University of Gothenburg | Academic/Hospital | 3 | 2 | 1 | 2017 |
| Gottfries Clinic AB | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Oslo | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1